Affiliation: | 1. Department of Respiratory and Intensive Care Medicine, National French Reference Constitutive Center for Rare Pulmonary Diseases, Hôpital François Mitterrand, Burgundy University Hospital, Dijon, France;2. INSERM UMR_S 999 “Pulmonary Hypertension: Pathophysiology and Novel Therapies”, Hôpital Marie Lannelongue, Le Plessis-Robinson, France;3. Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Pharmacy, Hôpital Bicêtre, Le Kremlin-Bicêtre, France;4. University of Paris-Saclay, Faculty of Pharmacy, Châtenay Malabry, France;5. AP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France;6. University of Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France;7. University of Bourgogne Franche-Comté, School of Medicine, Dijon, France;8. INSERM UMR 123-1, LNC Faculty of Medicine and Pharmacy, Dijon, France;9. Department of Respiratory Diseases, Hôpital Arnaud de Villeneuve, Montpellier University Hospitals, Montpellier, France;10. University of Montpellier, School of Medicine, Montpellier, France;11. INSERM U1046, Montpellier, France;12. Department of Respiratory Medicine, National Coordinating Reference Center for Rare Pulmonary Diseases, Hôpital Louis Pradel, Lyon, France;13. Claude-Bernard Lyon 1 University, University of Lyon, INRA, UMR754, Lyon, France;14. UMR 754, Lyon, France;15. Department of Cardiology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital de la Timone, Aix-Marseille University, Marseille, France;p. Internal Medicine Department, Hôpital Robert-Debré, Reims, France;q. Department of Cardiology, University Hospital of Bordeaux, Bordeaux, France;r. Department of Pathology, Hôpital Marie Lannelongue, Le Plessis-Robinson, France |